The original IV infusion formulation of Opdivo is approved for the treatment of 11 different types of cancer. The new injectable formulation is indicated—alone or in combination regimens—for most of ...

Luckily, a vast range of skilled and dedicated patient advocates can provide support to people with cancer and their loved ones. They raise funds and awareness, build programs and communities, share ...

The 2024 report underscores the role that alcohol use and infections, such as human papillomavirus (HPV), play in cancer incidence. In fact, 40% of cancer cases in the United States are linked to ...

“I was diagnosed with prostate cancer in 2007, and early detection saved my life,” said Arians, a former Super Bowl–winning head coach and prostate cancer survivor, in the Novartis press release. “I ...

Sugar has long been indirectly linked to an increase in cancer risk through obesity. However, a previous study by Yun’s lab challenged that view, showing that even moderate intake of sugary drinks ...

“The FDA approval of the first menin inhibitor is a major breakthrough for patients with relapsed or refractory acute leukemia with a KMT2A translocation, a genetic alteration associated with a very ...

The Food and Drug Administration this month approved Optune Pax, from Novocure—a wearable tumor-treating fields (TTFields) device that uses electric fields to kill cancer cells—for the treatment of ...

Other papers in the collection provided details about how various cancers develop and spread over time. For example, a team from Stanford University showed that colorectal tumors can contain ...

The researchers focused on enterotoxigenic Bacteroides fragilis (ETBF), a strain known to secrete a potent toxin that can remodel bacterial communities and promote cancer. When breast cancer cells or ...

Zoldonrasib is a novel RAS (ON) tri-complex inhibitor that selectively targets the G12D mutation. Unlike currently approved KRAS G12C-targeted therapies, which lock mutated KRAS in an inactive ...

After adjusting for several factors, they determined that areas with increased precipitation had a higher incidence of all cancers; they also noted that climate zone also significantly affected cancer ...

Treating advanced gastric or gastroesophageal junction cancer with Keytruda (pembrolizumab) is associated with similar overall survival time compared with chemotherapy in people with PD-L1–positive ...